Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Collaborator: University of California, San Diego
• Treatments: Brinzolamide; Timolol

Criteria

Inclusion Criteria:

• Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

• Women of childbearing potential

• History of bronchial asthma, or severe chronic obstructive pulmonary disease

• Presence of acute glaucoma